1. Home
  2. PBYI vs ALCY Comparison

PBYI vs ALCY Comparison

Compare PBYI & ALCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • ALCY
  • Stock Information
  • Founded
  • PBYI 2010
  • ALCY 2021
  • Country
  • PBYI United States
  • ALCY United States
  • Employees
  • PBYI N/A
  • ALCY N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • ALCY Blank Checks
  • Sector
  • PBYI Health Care
  • ALCY Finance
  • Exchange
  • PBYI Nasdaq
  • ALCY Nasdaq
  • Market Cap
  • PBYI 153.2M
  • ALCY N/A
  • IPO Year
  • PBYI N/A
  • ALCY 2023
  • Fundamental
  • Price
  • PBYI $3.09
  • ALCY $11.05
  • Analyst Decision
  • PBYI Strong Buy
  • ALCY
  • Analyst Count
  • PBYI 1
  • ALCY 0
  • Target Price
  • PBYI $7.00
  • ALCY N/A
  • AVG Volume (30 Days)
  • PBYI 754.5K
  • ALCY 367.0
  • Earning Date
  • PBYI 02-27-2025
  • ALCY 01-01-0001
  • Dividend Yield
  • PBYI N/A
  • ALCY N/A
  • EPS Growth
  • PBYI 492.79
  • ALCY 179.15
  • EPS
  • PBYI 0.47
  • ALCY 0.37
  • Revenue
  • PBYI $243,569,000.00
  • ALCY N/A
  • Revenue This Year
  • PBYI N/A
  • ALCY N/A
  • Revenue Next Year
  • PBYI N/A
  • ALCY N/A
  • P/E Ratio
  • PBYI $6.63
  • ALCY $29.86
  • Revenue Growth
  • PBYI 6.30
  • ALCY N/A
  • 52 Week Low
  • PBYI $2.23
  • ALCY $10.48
  • 52 Week High
  • PBYI $7.73
  • ALCY $13.14
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 49.17
  • ALCY 56.44
  • Support Level
  • PBYI $2.92
  • ALCY $11.01
  • Resistance Level
  • PBYI $4.06
  • ALCY $10.98
  • Average True Range (ATR)
  • PBYI 0.29
  • ALCY 0.00
  • MACD
  • PBYI 0.01
  • ALCY 0.02
  • Stochastic Oscillator
  • PBYI 27.07
  • ALCY 100.00

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About ALCY Alchemy Investments Acquisition Corp 1

Alchemy Investments Acquisition Corp 1 is a blank check company.

Share on Social Networks: